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ABSTRACT  
This work covers the study of antimicrobial and antiviral activities of the Aspergillus oryzae strain isolated from saline soil (El-Baida marsh in 
Algeria). The crude extract obtained with ethyl acetate displayed antimicrobial activity against Gram-positive and Gram-negative bacteria and 
the yeast Candida albicans with a mean of 16.69 mm of inhibition zone and a minimal inhibitory concentrations MICs between 7.28 and 21.85 
μgmL-1. We also assessed the antiviral activity against Herpes simplex-2 Virus (HSV-2), in which no inhibitory effect was exhibited. In addition, 
cytotoxicity activity was tested in Caco-2 and RAW 264, a human epithelial and a murine macrophage cell line, respectively, revealing a no-toxic 
effect of the extract. The studied isolate extract possesses an antimicrobial property and its non-toxicity to the host cells becomes very 
important, and can be exploited for the production of new pharmacological and biotechnological agents.  
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Filamentous fungi are extensive in the environment, and 
since a number of antibiotics have been isolated from 
different fungi such as Penicillium janczewskii, P. Canescens 
1,2 the interest of the researchers towards bioactive 
compounds having different biological activities had 
increased. The discovery of penicillin was a real invention in 
medicine, and the research's interest for searching new 
antimicrobial metabolites from microorganisms is 
continued. Many intensive studies, mainly on terrestrial-
derived and marine-derived fungi, displayed that fungi are a 
rich source of unique bioactive substances.3 
Fungi are important source of secondary metabolites with 
novel biological activities.4 Many fungal extracts substances 
have been found for their antimicrobial activity mainly from 
the fungus Penicillium,5 that they supply a rich source of 
compounds for therapeutic applications including 
antibacterial, antifungal and antiviral agents .2 Aspergillus 
oryzae is an important filamentous fungi in Japanese 
fermentation industry, as well as its capacity of the 
production of  various enzymes  makes it an perfect model 
for the research of protein secretion  and gene expression . 
A. oryzae has a great medicinal and pharmaceutical 
importance due to its ability to produce substances with 
antifungal activity such as Asperfuran and Oryzachlorin, in 
addition to antibiotics such as Penicillin. These 
countenances support the idea that A. oryzae is a suitable 
microorganism for fermentation and use in biotechnology.6 
Because of the increased interest of researchers in 
microorganisms and their applications in food as nutritional 
supplements, in health as therapeutic pharmaceuticals, and 
in industry as cosmetics, detergents. In addition, the interest 
of researchers is also attributed to the problem of salinity, 
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due to the transformation of vast agricultural areas annually 
into areas not suitable for agriculture. The question that 
arises is: If this soil is not suitable for agriculture, can it be 
exploited in other indirect ways in various fields? The aim of 
this study was to evaluate the antimicrobial and antiviral 
activities of the crude ethyl acetate extract of A. oryzae, 
isolated from saline soil, against some common pathogenic 
microorganisms, in addition to the study of its cytotoxicity. 
2. MATERIALS AND METHODS 
2.1. Study area 
El-Baida marsh is one of the natural saline soils. It is located 
between latitudes 5° 53' 20" E - 5° 53' 30" E and latitudes 
35° 57' 80" N - 35° 54' 20" N near Hammam El-Sukhna area 
(Setif region), an area of approximately 12.223 hectares. Soil 
surrounding the site is characterized by being less salty to 
salty, alkaline clay with a gradient composition.7 
2.2.  Culture media  
The synthetic (Yeast Extract Saccharose) YES medium 
consisting of sucrose 15% (w/v), yeast extract 2%, MgSO4 
0.05%, metal traces 0.1% (ZnSO4,7H2O 1%, CuSO4,7H2O 
0.5%)) was used for secondary metabolites production. 
Muller Hinton agar MHA and broth MHB were used for 
bacterial isolates culture and sensitivity tests. 
2.3.  Fermentation and Antimicrobial assay 
Seven days (potato dextrose agar) PDA plate fungal pure 
cultures were used to prepare discs. They were cut (6mm 
diameter) and placed into 250 mL Erlenmeyer flask 
containing 100mL of YES medium. The flasks were then 
incubated at 30 °C for 7 days. After fermentation, the 
mycelium with the medium was frozen at -10 °C for 2-3 
hours, then crushed and centrifuged at 15000 rpm / 15 
min.8 Finally; samples were extracted twice with equal 
volumes (1:1 v/v) of ethyl acetate. The organic layers were 
evaporated to dryness in a rotary evaporator at 40 ± 1°C, the 
dry crude extracts were then dissolved in DMSO 50% and 
stored at 4 °C until used.9,10 
2.3.1. Screening assay for antimicrobial activity using 
disc diffusion method 
Ethyl acetate extract of  A. oryzae was tested against a panel 
of human pathogenic microorganisms including, five Gram 
positive bacteria, (Bcillus aureus ATCC10876, Staphylococcus 
aureus ATCC25923, Staphylococcus aureus resistant to 
methicillin (SARM) ATCC43300, Listeria sp. and Enterococcus 
sp.), seven  Gram negative bacteria (Salmonella typhi  
ATCC14028, Escherichia coli  ATCC25922, Salmonella 
typhimirium  ATCC13311, Pseudomonas aeruginosa  
ATCC27853, Klebsiella  pneumonia  ATCC700603, Escherichia 
coli  resistant to a bactericide  ATCC35218, and  Salmonella 
entarica), and the yeast Candida albicans. Plates were 
prepared by spreading MHA and Sabouraud culture media 
by bacteria suspension 108 (Colony forming unit) CFU/mL 
and C.albicans 106 CFU/mL respectively, afterwards filter 
paper discs of 6 mm diameter were soaked with 20 μl of the 
fungal extracts and placed on the inoculated agar. The plates 
were then incubated at 37 °C, 24 h for bacterial isolates and 
48-72 h for the yeast.8 
Negative controls were prepared using the same solvents 
employed to dissolve the extracts. Antimicrobial activity was 
evaluated by measuring the zone of inhibition developed 
round the discs. Each assay in this experiment was 
performed in triplicate. 
 
2.3.2. Determination of the minimum inhibitory 
concentration (MIC) 
MIC is the lowest concentration that inhibits visible growth 
after time incubation period of 18-24 hours; here, its 
determination was made from the measurement of the 
turbidity induced by the growth of the studied germs.11 The 
MIC (µg/mL) of the crude extract of the fungus was 
determined using dilution method ELISA plate, where a 
series of two-fold dilutions (dissolved in DMSO up to 5% 
final DMSO concentration), were prepared in a 96 well-
sterile microplate. 100 μl of corresponding media (Muller 
Hinton Broth) MHB for the bacteria and PDB (Potato 
Dextrose Broth) for the yeast were added, then 100 µl of the 
diluted extract was introduced in each well. These dilutions 
were inoculated with 25 µl of a solution containing 6 x 107 
Colony Formatting Unit colony- forming unite per mL 
(CFU/mL) of bacterial suspension (Bcillus aureus 
ATCC10876, S. aureus ATCC25923, SARM ATCC43300, E. coli 
ATCC25922, P. aeruginosa ATCC27853, K. pneumonia, 
ATCC700603) and 7 x 107 CFU/mL of yeast suspension 
Candida albicans.12,8 The well-which used as a negative 
control was prepared using the inoculum alone. The 
microplate was incubated at 37 ◦C for 24 hour. The data was 
the mean of triplicates.13 
2.4. Antiviral activity essay 
Antiviral activity of A. oryzae extract was examined against 
Herpes simplex-2 (HSV-2), according to Anand et al.10 
method. Briefly, 60µl of HEp-2 monolayer cells (a type of 
human epithelial cell)  were grown in a plate of 96 wells and 
40µl of viral suspension, obtained by seven successive ten-
fold dilution in 2% FBS MEM (cow's serum / medium 
Minimum Basic), was added into five wells of microtiter 
plates (Four for antiviral, one as positive control and one 
without virus as negative control). The 96 well microplates 
were incubated at 37°C in 5% CO2 atmosphere for 60 
minutes to facilitate adsorption of virus to the cell line. The 
following concentrations of non-toxic fungal extracts of 40 
µg, 30 µg, 20 µg and 10 µg were diluted with 2% FBS, MEM 
and 100 µl of each concentration with the medium were 
transferred into the virus inoculated monolayer cell lines 
and reincubated at 37 °C temperature for 3-4 days to allow 
multiplication of virus and subsequent development of 
cytopathic effect (CPE). Each well was observed under 
Inverted microscope every day for presence or absence of 
cytopathic effect. The experiment was conducted under 
sterile conditions in duplicates. 
2.5. In vitro cytotoxicity test of A. oryzae extract in Caco-
2 cells and Raw 264 cells 
Cytotoxic activity of  A. oryzae extract in murine macrophage 
RAW 264 and human epithelial Caco-2 cells was performed 
using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay. This test is indicative for 
mitochondrial NADH-dependent dehydrogenase activity, 
which is proportional to both cell viability and proliferation 
rates of treated cultures.14 Both cell lines used, RAW 264 and 
Caco-2, were provided by the Cell Culture Unit of the 
University of Granada (Granada, Spain) and cultured in RPMI 
Medium, supplemented with 10% heat-inactivated fetal 
bovine serum,  L-glutamine (2 mmol/L), penicillin (100 
units/mL) and streptomycin (1 mg/mL) in a humidified 5% 
CO2 atmosphere at 37 °C. Cells were seeded into 96 well 
plates at a density of 5 x 105 cells/well, grown until the 
formation of a monolayer, and thus incubated with different 
concentrations of the extract (50 and 100 μg/mL), not 
exceeding 1 % DMSO in content, for 24 h. Untreated and 
DMSO-treated cells were used as controls. The effect of the 
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extract on cell viability was checked with the CellTiter 96® 
AQueous One Solution Cell Proliferation Assay (Promega, 
Madison, WI, USA) following the manufacturer’s protocol [3-
(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium] solution was added to each 
well and incubated for 1-4 h. The absorbance of the media 
was measured at 490 nm on a MRX Dynex microplate reader 
(Dynex Technologies, Chantilly, VA, USA). The cellular 
viability was calculated from the absorbance value and 
compared with that of the untreated control cells. 
3. RESULTS 
3.1. Antimicrobial assay 
A. oryzae isolate was tested for its antimicrobial activity, by 
disc diffusion method, it showed strong effects against the 
species tested with an inhibition zone diameters  ranging 
from 17.66 mm to 26 mm, the largest of which was against P. 
aeroginosa, followed by ERBC with 25 mm, then B. aureus by 
24 mm, and  SARM by 23 mm. Meanwhile, there was no 
effect on the bacteria Listeria sp., Enterococcus sp and 
Salmonella entarica. As for the yeast, C.allbicans the isolate 
had a clear effect with 18 mm (Figure 1). 
- The results showed that the MIC was 7.28 µg / ml for B. 
aureus and P. aeruginosa and 21.85 µg / ml for C. albicans 
and other tested bacteria (Table). 
3.2. In vitro cytotoxicity assay  
Incubation of Caco-2 and RAW 264 cells with different 
concentrations of A. oryzae extract (50 and 100 µg/ml) for 
24 h, did not exhibit cytotoxicity as determined by MTT 
assay. In fact, the viability in treated cells reached similar 
values of those in untreated and DMSO-treated controls 
(Figure 2 and 3).  
3.3. In vitro antiviral assay 
The non-toxic concentrations of secondary metabolites of 40 
µg, 30 µg, 20 µg and 10 µg were used for anti HSV-2 study. 
The secondary metabolites of A. oryzae did not show any 
inhibitory effect on HSV-2 and the complete cytopathic effect 
























































































Figure1: Antimicrobial activity of A. oryzae ethyl acetate 





Table 1: Minimal inhibitory concentrations of A. oryzae ethyl acetate extract developed against a panel of bacteria and yeast 
Microorganisms E. coli K. pneumoniae S. aureus SARM C. albicans B. aureus P. aeruginosae 
MIC (µg/mL) 21.85±0.35 07.28±0.13 
 
 
Figure 2:  Effects of A. oryzae extract on nitric oxide production in RAW 264 cells. The experiments were performed three 
times. 
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Figure 3: Cytotoxicity test of A. oryzae extract in CaCo-2 cells. The experiments were performed three times  
 
4. DISCUSSION 
The marsh (very salty lakes) constitutes rare regions in the 
world that seem to be promoter environments to isolate 
fungi source of new antimicrobial molecules.15 Fungal 
derived natural products have foremost served as lead 
structures for the development of antibacterial and antiviral 
agents .16  
In the present study, the fungal extract achieved the most 
activity against P. aeruginosa, B. aureus, E. coli-resistant and 
S. aureus-resistant bacteria. These findings are consistent 
with Bhattacharyya and Jha17 in their study of the 
antimicrobial activity of A. niger against Bacillus subtilis and 
C. albicans yeast. Same results obtained by Al-fakih and 
Almaqtri3 when testing the antibacterial activity of A. oryzae 
extract on seven bacterial species. However, the inhibition 
diameter ranged between 10-17.3 mm and the minimal 
inhibitory concentration (MIC) was between 176-285 µg / 
ml. Comparing with our results, this suggests that the 
isolated strain is better and more effective. 
These results obtained are important since these bacteria are 
known to be pathogenic and resistant to many antibiotics, as 
they are responsible for hospital infections18, such as S. 
aureus which is considered to cause skin infections19, and B. 
aureus responsible of infections in many diseases, and causes 
food poisoning.20 
Both Penicilium and Aspergillus are known for their extensive 
production of the same metabolites with various biological 
activities, including antibacterial and antifungal activities.3 
However initially, the antibiotics produced by Aspergilli were 
called aspirgillin, but recent studies have found that A. oryzae 
is able to produce several secondary metabolites with 
antibiotic effect  such as aspergillormarasmine, cyclopiazonic 
acid (CPA), kojic acid, 3-nitropropionic acid, maltorizine, 
violacetin, whose production has been investigated only on 
barley extract as an antibiotic21, in addition to Asperfuran as 
an antifungal agent22, as well as CJ-17.665A isolated from A. 
ochraceus.3 
A. oryzae fungus belongs to the family of A. flavus, but it 
doesn’t produce aflatoxin23, however, some mycotoxins have 
been isolated from A. oryzae, including kojic acid, and β-
nitropropionic acid (BNP). ), and cyclopiazonic acid (CPA), 
and some researchers have reported that kojic acid has 
strong inhibiting activity against tyrosinase and anti-
bacterial activity, while recent studies have shown that kojic 
acid may be a possible carcinogen.24 Unlike Seshime25, it is 
believed that the fungus contains the gene responsible for 
producing aflatoxin toxins but is inactive due to mutations in 
some regulatory genes. Regarding toxicity, our results 
demonstrate that the isolate A. oryzae has non-toxic effect. In 
fact, incubation of both murine macrophage RAW 264 and 
human epithelial Caco-2 cell lines with different 
concentrations of the extract for 24 hours did not affect cell 
viability.  These results are consistent with the study of  Sosa 
et al.26, who found that the fungus did not produce aflatoxin 
B1, B2, G1 , G2 as well as ochratoxin.  As a result, A. oryzae is 
a safe fungus and was listed as “Generally Recognized as 
Safe” by the Food and Drug Administration (FDA), and its 
safety was supported by the World Health Organization 
(WHO).24 Fungal strains used in industrial biotechnology 
have a long and documented history of a safe use of food and 
feed applications. Strains of A. niger and A. oryzae species 
have been used to ferment food for more than two thousand 
years and to manufacture food enzymes for more than 50 
years. Regulatory authorities consider hundreds of enzymes 
produced in these species safe.27 
The fact that the studied isolate extract possesses an 
antimicrobial property and its non-toxicity to the host cells 
becomes very necessary especially when it is used to prepare 
sterile or antiseptic substances or integrate it as one of the 
chemical components.28 
CONCLUSION 
From the above study, it is concluded that A. oryzae extract 
showed an antimicrobial activity against sensitive and 
resistant pathogenic microorganisms. Thus, it is of great 
importance in the treatment of pathologies associated with 
them because these strains exhibit high resistance to the 
antibiotics used in current therapeutic applications. 
However, to value this work it is necessary to follow it with 
purification and application in vivo of these bioactive 
substances, especially for its non-toxicity, so this isolate can 
be exploited for production of new pharmacological and 
biotechnological agents. 
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